(ENSG) The Ensign - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012

Skilled Nursing, Senior Living, Rehabilitation

Health Care Facilities
Market Cap in USD: 10,071m

IPO / Inception: 2007-11-09
12m vs SPY: 8.95%

EPS (Earnings per Share)

EPS CAGR: -44.31%
EPS Trend: -1.1%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 18.17%
Rev. Trend: 99.5%

Last SUE: 3.37
Qual. Beats: 2

Dividends

Dividend Yield	0.17%
Yield on Cost 5y	0.31%
Yield CAGR 5y	4.42%
Payout Consistency	98.6%
Payout Ratio	4.2%

Risk via 5d forecast
Volatility	23.1%
Value at Risk 5%th	35.7%
Relative Tail Risk	-6.22%

Reward TTM
Sharpe Ratio	1.01
Alpha	21.86
CAGR/Max DD	0.91

Character TTM
Hurst Exponent	0.664
Beta	0.470
Beta Downside	0.290

Drawdowns 3y
Max DD	23.49%
Mean DD	6.01%
Median DD	5.24%

Description: ENSG The Ensign January 07, 2026

The Ensign Group, Inc. (NASDAQ: ENSG) operates a network of skilled-nursing, senior-living, and rehabilitative facilities across 16 U.S. states, delivering both direct patient care (short- and long-term nursing, specialty services such as dialysis and ventilator management) and ancillary services (digital imaging, pharmacy, transportation). Its business is split between the Skilled Services segment, which provides the clinical and residential care, and the Standard Bearer segment, which generates lease income by renting post-acute care properties to other operators.

Key operating metrics show the company’s scale and financial health: as of FY 2023, ENSG reported approximately 6,200 licensed beds with an average occupancy rate of roughly 85%, and total revenue of $1.2 billion, reflecting a 5% year-over-year growth. EBITDA margins have hovered near 12%, while cash flow from operations remains positive, supporting ongoing capital expenditures and debt repayment. Sector-wide, the aging U.S. population and rising demand for post-acute care-driven by higher Medicare Advantage enrollment and tighter hospital discharge policies-are fundamental tailwinds for ENSG’s service lines.

For a deeper dive into ENSG’s valuation metrics, you might explore the analysis on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (328.2m TTM) > 0 and > 6% of Revenue (6% = 289.8m TTM)

FCFTA 0.06 (>2.0%) and ΔFCFTA 1.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 7.90% (prev 10.42%; Δ -2.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.09 (>3.0%) and CFO 481.4m > Net Income 328.2m (YES >=105%, WARN >=100%)

Net Debt (1.71b) to EBITDA (538.7m) ratio: 3.18 <= 3.0 (WARN <= 3.5)

Current Ratio 1.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (59.0m) change vs 12m ago 0.88% (target <= -2.0% for YES)

Gross Margin 15.65% (prev 15.51%; Δ 0.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 98.00% (prev 88.76%; Δ 9.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 53.02 (EBITDA TTM 538.7m / Interest Expense TTM 8.29m) >= 6 (WARN >= 3)

Altman Z'' 2.68

(A) 0.07 = (Total Current Assets 1.21b - Total Current Liabilities 825.2m) / Total Assets 5.23b

(B) 0.32 = Retained Earnings (Balance) 1.66b / Total Assets 5.23b

(D) 0.54 = Book Value of Equity 1.66b / Total Liabilities 3.10b

Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 76.53

1. Piotroski 7.50pt

2. FCF Yield 2.47%

3. FCF Margin 6.00%

4. Debt/Equity 1.02

5. Debt/Ebitda 3.18

6. ROIC - WACC (= 10.01)%

7. RoE 16.62%

8. Rev. Trend 99.49%

9. EPS Trend -1.13%

What is the price of ENSG shares?

As of January 12, 2026, the stock is trading at USD 173.87 with a total of 167,199 shares traded.
Over the past week, the price has changed by -1.50%, over one month by -0.12%, over three months by -1.74% and over the past year by +31.59%.

Is ENSG a buy, sell or hold?

The Ensign has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy ENSG.

Strong Buy: 4
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ENSG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	208.2	19.7%
Analysts Target Price	208.2	19.7%
ValueRay Target Price	211.1	21.4%

ENSG Fundamental Data Overview January 11, 2026

P/E Trailing = 31.0482
P/E Forward = 24.0385
P/S = 2.0854
P/B = 4.8158
P/EG = 1.6026
Beta = 0.862
Revenue TTM = 4.83b USD
EBIT TTM = 439.6m USD
EBITDA TTM = 538.7m USD
Long Term Debt = 138.6m USD (from longTermDebt, last quarter)
Short Term Debt = 115.0m USD (from shortTermDebt, last quarter)
Debt = 2.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.71b USD (from netDebt column, last quarter)
Enterprise Value = 11.72b USD (10.07b + Debt 2.16b - CCE 506.3m)
Interest Coverage Ratio = 53.02 (Ebit TTM 439.6m / Interest Expense TTM 8.29m)
EV/FCF = 40.48x (Enterprise Value 11.72b / FCF TTM 289.5m)
FCF Yield = 2.47% (FCF TTM 289.5m / Enterprise Value 11.72b)
FCF Margin = 6.00% (FCF TTM 289.5m / Revenue TTM 4.83b)
Net Margin = 6.80% (Net Income TTM 328.2m / Revenue TTM 4.83b)
Gross Margin = 15.65% ((Revenue TTM 4.83b - Cost of Revenue TTM 4.07b) / Revenue TTM)
Gross Margin QoQ = 14.67% (prev 16.19%)
Tobins Q-Ratio = 2.24 (Enterprise Value 11.72b / Total Assets 5.23b)
Interest Expense / Debt = 0.09% (Interest Expense 1.97m / Debt 2.16b)
Taxrate = 21.28% (22.7m / 106.6m)
NOPAT = 346.0m (EBIT 439.6m * (1 - 21.28%))
Current Ratio = 1.46 (Total Current Assets 1.21b / Total Current Liabilities 825.2m)
Debt / Equity = 1.02 (Debt 2.16b / totalStockholderEquity, last quarter 2.12b)
Debt / EBITDA = 3.18 (Net Debt 1.71b / EBITDA 538.7m)
Debt / FCF = 5.92 (Net Debt 1.71b / FCF TTM 289.5m)
Total Stockholder Equity = 1.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.66% (Net Income 328.2m / Total Assets 5.23b)
RoE = 16.62% (Net Income TTM 328.2m / Total Stockholder Equity 1.98b)
RoCE = 20.80% (EBIT 439.6m / Capital Employed (Equity 1.98b + L.T.Debt 138.6m))
RoIC = 16.33% (NOPAT 346.0m / Invested Capital 2.12b)
WACC = 6.31% (E(10.07b)/V(12.23b) * Re(7.65%) + D(2.16b)/V(12.23b) * Rd(0.09%) * (1-Tc(0.21)))
Discount Rate = 7.65% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.21%
[DCF Debug] Terminal Value 84.19% ; FCFF base≈251.0m ; Y1≈241.3m ; Y5≈236.1m
Fair Price DCF = 77.89 (EV 6.22b - Net Debt 1.71b = Equity 4.51b / Shares 57.9m; r=6.31% [WACC]; 5y FCF grow -5.16% → 2.90% )
EPS Correlation: -1.13 | EPS CAGR: -44.31% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.49 | Revenue CAGR: 18.17% | SUE: 3.37 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.75 | Chg30d=+0.006 | Revisions Net=+4 | Analysts=5
EPS next Year (2026-12-31): EPS=7.27 | Chg30d=+0.022 | Revisions Net=+3 | Growth EPS=+11.7% | Growth Revenue=+12.6%

Additional Sources for ENSG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle